-
Proteostasis Dosing in Phase 2 Testing of 3 CF Investigational Therapies
The first patient has been dosed in a Phase 2 clinical trial testing Proteostasis Therapeutics’s combinations of three investigational therapies for CF. Click here to read the full story.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.